forward-looking probe during DBS surgery can detect blood flow peaks and further minimize the risk of developing ICH. No separate guide tube is necessary as the probe also creates the trajectory for the DBS lead.
hematomas are detected on postoperative CT or MRI follow-ups and can be asymptomatic. The incidences of hemorrhages in different studies are varying. Fenoy and Simpson [4] presented a retrospective summary of adverse events in 728 DBS patients treated by 1 neurosurgeon. In their study 3.4% had asymptomatic intraventricular hemorrhage, 1.1% presented symptomatic ICH and 0.5% had asymptomatic ICH. Several studies have looked into whether intraoperative microelectrode recording (MER) increases the risk of hemorrhagic complications. Gorgulho et al. [5] report from their study that 2.9% of patients undergoing MER presented with hemorrhage compared with 1.4% of patients undergoing only macrostimulation. Xiaowu et al. [1] reported in their study of 644 patients that MER provides useful information for guiding surgery, but the procedure carries a risk of intracranial hemorrhage due to multiple electrodes and the sharp tips of these microelectrodes. Other studies have not shown any increase in hemorrhagic complications using MER. Zibetti et al. [6] describe a consecutive study of 221 patients with a total of 442 quadripolar electrodes implanted using MER, no association of an increased risk of ICH using MER if the patient selection is made carefully and the surgical procedure is done by a well-trained team. Another intraoperative physiological method to help identify anatomical borders is the recording of local field potentials using the macroelectrode [7] . Dynamic intraoperative impedance measurement is yet another method used by some surgeons [8] . The issue of proving the best possible safety for these patients undergoing the procedure is crucial, most of the described safety procedures like MER are for improving targeting, yet the most devastating complication is ICH. A considerable number of the patients are treated for hypertension, which is a risk factor for ICH due to the vasosclerosis in the patients [9] . Patients with medicated hypertension should have wellcontrolled blood pressure prior to surgery. Meticulous trajectory planning and optimal MRI sequences are some of the possible measures that can be done. For further decreasing the numbers of ICH and aiming for a zero ICH vision, it is also necessary to introduce intraoperative measurement techniques that can reduce the risk for hemorrhage and thus identify vessel structures along the trajectories. This is important not only for DBS surgery, but also for other types of stereotactic interventions such as radiofrequency lesioning and biopsy procedures.
One way already explored by us is the ability to in vivo monitor the microcirculation when creating the trajectory for the DBS lead by means of laser Doppler flowmetry (LDF) and a forward-looking probe. LDF is a wellexplored method for monitoring skin and other tissues' microcirculation [10] and has previously been adapted to stereotactic neurosurgery [11, 12] . An additional advantage with LDF is that it can also detect gray-white tissue boundaries in a similar way as reflectance spectroscopy performed in the near-infrared wavelength interval [12] [13] [14] [15] [16] . A review of the steps in developing a tool for optical intraoperative guidance during stereotactic procedures is presented in Wårdell [17] . In the present study, a retrospective safety analysis using the optical navigation technique is presented for 83 lead implantations at the Department of Neurosurgery, Linköping University Hospital. The aim of the study was to investigate the applicability and safety of the LDF measurements during stereotactic DBS implantations.
Material and Methods

Patients
Fifty patients (18 female and 32 male) aged between 41 and 81 years (mean ± SD, 65 ± 9 years) referred for uni-or bilateral DBS implantation at the Department of Neurosurgery, Linköping University Hospital, were included in the study over a 10-year period (September 2005 to June 2016). In total 83 leads were implanted: 24 in the ventral intermediate nucleus (VIM), 38 in the subthalamic nucleus (STN), 8 in the globus pallidum internus (GPi), 12 in the zona incerta (ZI), and 1 patient had a DBS lead implanted due to facial pain in the ventral posteromedial nucleus (VPM) of the thalamus. The studies were approved by the local ethics committee at the University Hospital in Linköping (D. No. M182-04, T54-09), and informed written consent was received from the patients.
Surgery
The surgical procedures followed the protocol of an imageguided frame-based approach to the STN, GPi, and ZI targets. For indirect targeting (VIM and VPM), a stereotactic CT (slice thickness 1 mm, GE Lightspeed Ultra, GE Healthcare, UK) was performed on the day of surgery with the Leksell Stereotactic System ® (LSS, Model G, Elekta Instrument AB, Sweden). The stereotactic CT was image fused with a preoperative MRI. Direct anatomical targeting of the STN, ZI, and GPi was done using stereotactic 1.5-T or 3-T MRI (T1-and T2-weighted, slice thickness 2 mm, Philips Intera, the Netherlands). Indirect targeting of the VIM nucleus was performed and optimally the tip of the electrode was located on the AC-PC plane, 6-7 mm in front of the PC with a laterality of 12-14 mm from the midline [11, 18] . Targeting and planning of the trajectories were performed in the Leksell ® Surgiplan System (Elekta Instrument AB, Sweden). Patients undergoing DBS implantation for STN, GPi, and ZI targets underwent the procedure in 1 stage under general anesthesia. Patients with essential tremor undergoing VIM surgery had their procedure done in 2 steps where the placement of the electrodes was done under local anesthesia so that the patients could be evaluated clinically with macrostimulation. MER was not performed in any of the cases in this review. The 394 optical probe was used to create a trajectory and replaced the conventional guide used before. The trajectories were planned meticulously avoiding visible blood vessels, sulci and the lateral ventricles. All procedures were done by the same 2 surgeons.
Postoperative Imaging
All 50 patients included from Linköping in the study were postoperatively examined with CT or MRI and coregistered with preoperative stereotactic MRI using Surgiplan software for confirmation of lead positions. Since 2010 the postoperative examination has been performed within 24 h from implantation, and therefore these patients can be evaluated not only for lead positioning, but also for any visible hemorrhage on the postoperative CT scan. Thirty-one patients in the study had the postoperative scan within 24 h and were evaluated for the presence of hemorrhage by a neurosurgeon and a neuroradiologist. Nineteen patients had their scan for evaluating lead positioning within a year from initial surgery but since there is no examination in the immediate postoperative period (24-48 h), it cannot be excluded that there could have been small amounts of blood even though the patients showed no neurological symptoms from a suspected hemorrhage.
Optical Measurements
System and Probe An LDF system (Periflux 5000, Perimed AB, Sweden) adapted and approved for clinical use at Linköping University Hospital during stereotactic neurosurgery was used for all the measurements. An in-house software in LabVIEW (National Instruments Inc., TX, USA) made it possible to record both the brain tissue's microcirculation (also denoted blood flow or perfusion) and the backscattered total light intensity (TLI) which corresponds to the grayness of the tissue. The total measurement ranges of the perfusion and TLI signals are presented as 0-999 arbitrary units (AU) and 0-10 AU, respectively. In the present LDF system, a TLI >0.5 AU is required in order to process a perfusion signal. Low-power laser light (wavelength 780 nm, effect 1 mW) is transmitted to the tissue from the LDF through an optical fiber positioned along the stainless-steel shaft of the measurement probe. Receiving light is transmitted back to the LDF through the same probe for signal processing and presentation of the recorded result online in the operating room. The probe's outer dimension was adapted to fit the LSS (length 190 mm, diameter 2 mm except for the last 30 mm where it is 1.5 mm), and with a forward-looking smoothly rounded tip. Prior to each surgical procedure, the probe was tested in a calibration solution (Motility Solution, Perimed AB, Sweden), and 395 if necessary the LDF was recalibrated in order to make the measurements comparable, thereafter the probe was cleaned and sterilized using the STERRAD ® procedure [19] . Figure 1 presents the measurement setup in the operating room and Figure 2 the probe as positioned in the LSS and the mechanical insertion device (Fig. 2a) and a sketch of the forward-looking probe (Fig. 2b) . A more detailed presentation of the system and the probe can be found in Wårdell et al. [12] .
Measurement Procedures A similar measurement principle was used for all surgical procedures, but the insertion of the probe and measurement positions varied. In the first 8 trajectory recordings the probe was inserted manually by the surgeon. During these measurements the optical probe was carefully pushed down to -30, -20, -10, -5, and -2.5 mm from the precalculated target and finally moved to the target region. For this setup the perfusion and TLI signals were recorded during a total time period of 30 s per site [11] . In the remaining surgeries the mechanical hand-driven device was used to insert the probe in a millimeter precision controlled manner. As the initial measurements showed that the laser Doppler system presents a stable signal already within a few seconds after movement with the mechanical device from one position to another, the measurement time at each position could be reduced to about 10 s. When the mechanical device was used, a recording was always done in the cortex, in white matter at the internal capsule as well as in the target region. For 22 implantations measurements were performed along the entire trajectory, i.e. all the way from the cortex towards the respective target with a distance between measurement positions of 1 mm [12] . For a second group of patients including 20 lead implantations, a more detailed investigation of the microcirculation and tissue type was done starting 10 mm from the precalculated target and by using increments of 0.5 mm between measurement sites [20] . Along 23 of the trajectories, measurements were also performed 1-3 mm beyond the target. Additionally, the probe was used as guide to create the path for the leads simultaneously as LDF recordings in 33 patients.
Data Analysis
All medical patient charts and postoperative radiology were retrospectively reviewed for hypertension, postoperative hemorrhage and DBS lead infections.
All measurement positions were reviewed from a microcirculatory perspective. As the microvascular blood flow in general is low (usually <50 AU), 50 AU was used as the threshold. Blood flow values being at least twice as high (>100 AU) were considered as high blood flow spots. Furthermore, these were divided into the following groups: A = 101-250 AU, B = 251-500 AU, and C = >500 AU according to previously presented analysis [12] . In addition, the spots with increased blood flow were compared with the TLI signals at the same site. At 52 sites the TLI was less than 0.5 AU, it was not possible to process the perfusion signal because of the little reflected light. If such low TLI values appeared next to a high blood flow peak, they were set to the maximum perfusion value of 999 AU. A typical LDF recording is shown in Figure 3 , and the A, B, and C perfusion levels are marked with lines in order to exemplify high blood flow values.
Results
The retrospective safety analysis showed that all patients under systemic anticoagulation therapy, e.g. warfarin, had their medication discontinued 3-5 days before surgery. All of the patients received tinzaparin sodium, a low-molecular-weight heparin the evening before surgery (10,000 anti-Xa IE/mL, 0.25 mL) for thromboembolism prevention. The patients undergoing the procedure under general anesthesia (n = 35) received their anesthesia intravenously with propofol and remifentanil. Thirtysix of the patients had a history of hypertension and were on antihypertensive treatment at the time of surgery. All Of the 2,963 LDF measurement positions, 234 (7.9%) showed at least a doubled microvascular blood flow compared to the surrounding tissue. Of these measurements sites 131 (4.2%) were A peaks. At 38 sites (1.3%) the blood flow belonged to the B group and at 65 (2.2%) to the C group, i.e. had a more than 5 times higher blood flow in front of the probe tip. Of the C values 52 were set to 999 AU. The high blood flow peaks were most frequent in the cortex close to sulci, in the vicinity to the ventricles, and along VIM trajectories. In total 30 trajectories presented high flow peaks. Of these 15 were along VIM, 8 along STN, 6 along GPi, and 1 along ZI trajectories. All trajectories except 1 were recorded without adverse events. In 1 patient the stereotactic frame detached during surgery, and the LDF system showed an atypical measurement. Due to this the surgery was inhibited. A postoperative CT scan revealed a small ICH along the trajectory as presented in Figure 4 together with a mean curve of 11 optical trajectories towards the VIM (see also Wårdell et al. [12] ). The patient was asymptomatic and admitted 3 months later for new DBS surgery. A left-sided ventricular involvement in 1 patient is clearly visualized (Fig. 5a, b) as increased microvascular blood flow can be seen and a deeper dip in the TLI signal compared to the right-hand side (Fig. 5a, c) . The measurement time required for each trajectory was 7-15 min depending on the number of positions and measurement time at each site. 
Discussion
In this study 83 DBS lead implantations performed with an optical guide for creation of the trajectory have been reviewed from safety aspects. The study shows that this optical guide with a forward-looking feature can help indicate regions with increased blood flow as well as distinguish between the tissue's grayness.
DBS surgery and other functional neurosurgical procedures aim at improving quality of life in patients with progressive neurological diseases, e.g. Parkinson disease. It is therefore very important to reduce surgical risks that can cause further disability for the patients. In neurosurgery there is a constant development of intraoperative monitoring techniques. Well-established monitoring techniques include neurophysiological monitoring in spinal and tumor surgery, intraoperative MRI in surgery of low-grade gliomas and awake craniotomy. In DBS surgery the most widespread and frequently used intraoperative monitoring technique for optimizing the implantation position for the lead in anesthetized patients is MER. There are no techniques in clinical use for routinely measuring the microcirculation in vivo during the stereotactic surgical procedure.
The incidence of hemorrhage in DBS surgery is low but it can be the most devastating complication. Tonge et al. [21] report from a recent published study an overall calculated risk of an ICH to be 1.81% per patient, 0.94 per side. To identify patient risk factors, high-quality MRI and meticulous planning of trajectories including avoiding brain sulci and ventricles are important steps to minimize the risk of hemorrhage [22] . Even with high-quality MRI small vessels in front of the guiding tube or electrode cannot be visualized; therefore a method for online, in vivo measurement of the brain microcirculation deep in the brain in front of the guiding tube could further increase patient safety by reducing the incidence of hemorrhage. LDF for measuring the microcirculation during stereotactic surgery is a safe method with no complications reported in our material and it is not especially time consuming. A recording along 1 lead is done within 7-15 min, depending on the protocol. The mechanical device used and described is easy to handle for the surgeon and also the interpretation of the perfusion curves. The LDF technique can further decrease risks of hemorrhage in this already vulnerable group of patients. It can also be used for all targets in DBS surgery and for other stereotactic procedures like biopsies of deep brain tumors. New probe designs would also allow MER in combination with LDF. The LDF can be used for patients undergoing procedures both under general anesthesia and local anesthesia. The purpose of this study was to review the optical measurements performed in 50 patients. A weakness with the study is that the first 19 patients did not routinely undergo postoperative radiology within 24 h. During the course of the study, however, the DBS implantation procedure has successively been improved including today routine postoperative imaging. Furthermore the entire procedure is done in 1 session and with general anesthesia in order to reduce the discomfort of the patient. The total time today is about 4 h for a unilateral and 5 h for a bilateral procedure including LDF measurements and pulse generator implantation. All recordings were done with the same type of forward-looking probe, but with various measurement protocols and methodological improvements. During surgery the probe was used as a guide creating the trajectory for the DBS lead at the same time as the hyperperfused tissue in the vicinity to the probe tip was presented online in the operating room together with gray-white tissue changes. At the present time, the "bar codes" for optical trajectories are processed postoperatively. An improvement in a future system would be to present both the blood flow peaks and "bar codes" in real time together with the preoperative images.
Conclusion
The risk of developing ICH as presented in the literature varies, probably due to variations in preoperative assessment and surgical approaches and how different centers manage this problem. In this study 83 DBS lead implantations show that the probe with optical fibers does not increase the hemorrhage incidence compared to other intraoperative measurement techniques. Instead the probe's forward-looking feature can identify increased blood flow in the vicinity to potential vessel structures and also acts as an intraoperative guidance method for distinction between shades of gray matter and white matter along the predefined trajectory. As the probe also acts as the guide and thus creates the trajectory for the DBS lead, no separate guide tube is necessary.
